3-((11R,14R,17R,20R,23R,26R,34R)-38-amino-26-carbamoyl-11,14,17,20,23-pentakis(3-guanidinopropyl)-31-imino-1-(isoquinoline-5-sulfonamido)-9,12,15,18,21,24,33-heptaoxo-3,10,13,16,19,22,25,30,32-nonaazaoctatriacontan-34-ylcarbamoyl)-4-(3,6-bis(dimethylamino)-3H-xanthen-9-yl)benzoic acid (Compound)
Analyze
The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 3-((11R,14R,17R,20R,23R,26R,34R)-38-amino-26-carbamoyl-11,14,17,20,23-pentakis(3-guanidinopropyl)-31-imino-1-(isoquinoline-5-sulfonamido)-9,12,15,18,21,24,33-heptaoxo-3,10,13,16,19,22,25,30,32-nonaazaoctatriacontan-34-ylcarbamoyl)-4-(3,6-bis(dimethylamino)-3H-xanthen-9-yl)benzoic acid's neighborhood in the knowledge graph.
The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for 3-((11R,14R,17R,20R,23R,26R,34R)-38-amino-26-carbamoyl-11,14,17,20,23-pentakis(3-guanidinopropyl)-31-imino-1-(isoquinoline-5-sulfonamido)-9,12,15,18,21,24,33-heptaoxo-3,10,13,16,19,22,25,30,32-nonaazaoctatriacontan-34-ylcarbamoyl)-4-(3,6-bis(dimethylamino)-3H-xanthen-9-yl)benzoic acid.
The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with 3-((11R,14R,17R,20R,23R,26R,34R)-38-amino-26-carbamoyl-11,14,17,20,23-pentakis(3-guanidinopropyl)-31-imino-1-(isoquinoline-5-sulfonamido)-9,12,15,18,21,24,33-heptaoxo-3,10,13,16,19,22,25,30,32-nonaazaoctatriacontan-34-ylcarbamoyl)-4-(3,6-bis(dimethylamino)-3H-xanthen-9-yl)benzoic acid.
Results found
Linked to
3-((11R,14R,17R,20R,23R,26R,34R)-38-amino-26-carbamoyl-11,14,17,20,23-pentakis(3-guanidinopropyl)-31-imino-1-(isoquinoline-5-sulfonamido)-9,12,15,18,21,24,33-heptaoxo-3,10,13,16,19,22,25,30,32-nonaazaoctatriacontan-34-ylcarbamoyl)-4-(3,6-bis(dimethylamino)-3H-xanthen-9-yl)benzoic acid bioactivity Ribosomal protein S6 kinase beta-1
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG
3-((11R,14R,17R,20R,23R,26R,34R)-38-amino-26-carbamoyl-11,14,17,20,23-pentakis(3-guanidinopropyl)-31-imino-1-(isoquinoline-5-sulfonamido)-9,12,15,18,21,24,33-heptaoxo-3,10,13,16,19,22,25,30,32-nonaazaoctatriacontan-34-ylcarbamoyl)-4-(3,6-bis(dimethylamino)-3H-xanthen-9-yl)benzoic acid bioactivity RAC-gamma serine/threonine-protein kinase
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG
3-((11R,14R,17R,20R,23R,26R,34R)-38-amino-26-carbamoyl-11,14,17,20,23-pentakis(3-guanidinopropyl)-31-imino-1-(isoquinoline-5-sulfonamido)-9,12,15,18,21,24,33-heptaoxo-3,10,13,16,19,22,25,30,32-nonaazaoctatriacontan-34-ylcarbamoyl)-4-(3,6-bis(dimethylamino)-3H-xanthen-9-yl)benzoic acid bioactivity cGMP-dependent protein kinase 1
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG
3-((11R,14R,17R,20R,23R,26R,34R)-38-amino-26-carbamoyl-11,14,17,20,23-pentakis(3-guanidinopropyl)-31-imino-1-(isoquinoline-5-sulfonamido)-9,12,15,18,21,24,33-heptaoxo-3,10,13,16,19,22,25,30,32-nonaazaoctatriacontan-34-ylcarbamoyl)-4-(3,6-bis(dimethylamino)-3H-xanthen-9-yl)benzoic acid bioactivity Ribosomal protein S6 kinase alpha-5
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG